Pneumococcal conjugate second or third-dose vaccines (PCVc) in Tanzania
Tanzania: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 82.0% in 2025. ◆ Volatile
Latest (2025)
82.0%
Change on year
unchanged
World rank
106th
of 194 countries
All-time high
93.0%
in 2014
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Tanzania, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Tanzania recorded 82.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) in 2025.
The figure is down 11.8% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Tanzania peaked at 93.0% in 2014 and was at its lowest, 0.0%, in 2008.
Tanzania ranks 106th of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Tanzania, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 80.0% | — |
| 2014 | 93.0% | +16.2% |
| 2015 | 93.0% | +0.0% |
| 2016 | 93.0% | +0.0% |
| 2017 | 93.0% | +0.0% |
| 2018 | 93.0% | +0.0% |
| 2019 | 90.0% | -3.2% |
| 2020 | 89.0% | -1.1% |
| 2021 | 86.0% | -3.4% |
| 2022 | 85.0% | -1.2% |
| 2023 | 82.0% | -3.5% |
| 2024 | 82.0% | +0.0% |
| 2025 | 82.0% | +0.0% |
Tanzania compared with similar countries
- Tanzania's 82.0% is below the median for lower middle income countries, which is 84.0%, 98% of the median. (47 countries reporting)
- Tanzania's 82.0% is below the median for Sub-Saharan Africa, which is 82.5%, 99% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 63.5% | 0.0% | 93.0% | 10 |
| 2020s | 84.3% | 82.0% | 89.0% | 6 |
Countries ranked near Tanzania
More health data for Tanzania
- Un projection of annual infant deaths, annual growth rate -1.03 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7342 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 658.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 32,514 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 13 (2025)
- Population ages 00-04, female, annual growth rate 1.86 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0786 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.89 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Tanzania?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Tanzania was 82.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Tanzania?
- The highest recorded value was 93.0% in 2014.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Tanzania?
- The lowest recorded value was 0.0% in 2008.
- How does Tanzania rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Tanzania ranks 106th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Tanzania?
- Over the last ten years it is down 11.8%. The long-run trend across the full record is volatile.
- Where does this Tanzania data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).